This guarantee provides peace of mind for potential customers and reflects the brand ... COPD, promotes deeper breathing, targets mucus buildup, and provides a natural alternative to inhalers ...
What are the symptoms of emphysema? - Understanding the condition is the first step towards taking control of your lung ...
3/4 inhibitor – now given the somewhat tongue-twisting brand name of Ohtuvayre – is the first inhaled product with a novel mechanism of action available for the maintenance treatment of COPD ...
In 2024, the Hatch-Waxman Act continued to play a critical role in the U.S. pharmaceutical landscape, driving the dynamics between ...
Patients with COPD had slightly more major adverse cardiovascular events after initiating single-inhaler triple therapy vs a LABA-ICS inhaler.
“We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio.
"We are proud to continue advancing our asthma and COPD inhaled drug program, achieving key clinical development milestones on schedule,” said Xian-Ming Zeng, Ph.D., CEO of Transpire Bio. "These ...
AstraZeneca’s Fasenra, an IL-5-targeting monoclonal antibody already approved for asthma, represents a promising contender ...
It's also important to remember that some inhalers are meant only for people diagnosed with chronic obstructive pulmonary disease (COPD) and don't treat asthma. These medications include: In many ...
A high-tech device that can monitor medication use and compliance has been cleared by the FDA for use with AstraZeneca’s Airsupra and Breztri inhalers. Developed by Australian medtech firm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback